北京东方中科集成科技股份有限公司 北京东方中科集成科技股份有限公司（以下简称"公司"）拟就 发行股份购买资产所涉部分业绩承诺方业绩承诺补偿事项提起仲裁， 现将具体情况公告如下： 一、拟提起仲裁事项的基本情况 1、拟仲裁当事人 申请人：北京东方中科集成科技股份有限公司 被申请人：万里锦程创业投资有限公司、刘达、杭州明颉企业管 理有限公司、赵国、张林林、珠海华安众泓投资中心（有限合伙）、 珠海华安众泰投资中心（有限合伙）、王秀贞、刘顶全、张小亮、孙 文兵、北京泰和成长控股有限公司、余良兵、珠海众诚联合投资中心 （有限合伙）。 证券代码：002819 证券简称：东方中科 公告编号：2023-069 2、拟仲裁理由 关于公司就业绩承诺补偿事项拟提起仲裁的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 交易对方本次业绩补偿安排具体如下： | 5 | 青岛精确智芯股权投资合伙企业 | 1,224,049 | 183,607.35 | | --- | --- | --- | --- | | | （有限合伙） | | | | 6 | 珠海格力创业投资有限公司 | 1,2 ...

北京东方中科集成科技股份有限公司 2023年半年度非经营性资金占用及其他关联资金往来情况汇总表 编制单位：北京东方中科集成科技股份有限公司 单位：万元 | 其他关联资金往来 | 资金往来方名称 | 往来方与上市公司的关联关系 | 上市公司核算 的会计科目 | 2023年期初占用 资金余额 | 2023年半年度占 用累计发生金额 | 2023年半年度 占用资金的利息 | 2023年半年度 偿还累计发生 | 2023年半年度 期末占用资金 | 往来形成原因 | 往来性质 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | | （不含利息） | (如有) | 金额 | 余额 | | | | 上市公司的子公司及其附属 企业 | 东科（上海）商业保理有限公司 | 控股子公司 | 其他应收款 | 18,000.00 | 395.00 | | 2,395.00 | 16,000.00 业务往来 | | 非经营性往来 | | | 北京东方天长科技服务有限公司 | 控股子公司 | 其他应收款 | 500.00 | 11. ...

北京市中伦律师事务所 二〇二三年八月 北京 • 上海 • 深圳 • 广州 • 武汉 • 成都 • 重庆 • 青岛 • 杭州 • 南京 • 海口 • 东京 • 香港 • 伦敦 • 纽约 • 洛杉矶 • 旧金山 • 阿拉木图 Beijing • Shanghai • Shenzhen • Guangzhou • Wuhan • Chengdu • Chongqing • Qingdao • Hangzhou • Nanjing • Haikou • Tokyo • Hong Kong • London • New York • Los Angeles • San Francisco • Almaty 法律意见书 北京市朝阳区金和东路 20 号院正大中心 3 号南塔 22-31 层 邮编：100020 22-31/F, South Tower of CP Center, 20 Jin He East Avenue, Chaoyang District, Beijing l00020, P.R. China 电话/Tel : +86 10 5957 2288 传真/Fax : +86 10 6568 1022/183 ...

第五届董事会第二十一次会议独立董事意见 根据《中华人民共和国公司法》《上市公司独立董事规则》《深 圳证券交易所股票上市规则》等有关法律、法规和规范性文件以及《公 司章程》的规定，我们作为北京东方中科集成科技股份有限公司（以 下简称"公司"）的独立董事，对公司第五届董事会第二十一次会议审 议的议案及相关事项发表了如下独立意见： 北京东方中科集成科技股份有限公司 一、关于公司 2023 年半年度募集资金存放与使用情况专项报告 的独立意见 根据相关的法律法规和公司《募集资金管理制度》的规定，我们 对公司2023年半年度募集资金专户存储、募集资金使用、募集资金管 理与监督以及信息披露等事项进行了审核。2023年上半年度公司募集 资金的存放和实际使用符合中国证监会、深圳证券交易所关于上市公 司募集资金存放和使用的相关规定，不存在募集资金存放和实际使用 违规的情形。公司董事会编制的《2023年半年度募集资金存放与使用 情况的专项报告》符合相关法律、法规的规定，真实、准确、完整地 反映了2023年半年度公司募集资金的存放与实际使用情况。 二、关于控股股东及其他关联方占用公司资金、公司对外担保情 况的专项说明和独立意见 根据 ...

证券代码：002819 证券简称：东方中科 公告编号：2023-064 北京东方中科集成科技股份有限公司 第五届董事会第二十一次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 北京东方中科集成科技股份有限公司（以下简称"公司"）第五 届董事会第二十一次会议于 2023 年 8 月 29 日以通讯方式召开，会议 以投票方式表决。会议通知已于 2023 年 8 月 18 日通过专人送达、邮 件等方式送达给全体董事。本次会议应到董事 9 名，实到董事 9 名。 会议的召集、召开程序符合《公司法》和《公司章程》的有关规定。 会议由董事长王戈先生主持，与会董事对各项议案进行审议、表 决，形成如下决议： 1、审议通过《<2023 年半年度报告全文>及摘要》 详情请参考公司指定披露媒体《中国证券报》《上海证券报》《证 券日报》《证券时报》及巨潮资讯网（www.cninfo.com.cn）披露的《2023 年半年度报告》及《2023 年半年度报告摘要》。 表决结果：9 票同意，0 票反对，0 票弃权。 2、审议通过《董事会关于 2023 年半年度募集资金存放与使 ...

激励计划股票期权行权价格的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 北京东方中科集成科技股份有限公司（以下简称"公司"）于 2023 年 8 月 29 日召开第五届董事会第二十一会议和第五届监事会第十八 次会议，审议通过了《关于调整 2020 年股票期权与限制性股票激励 计划股票期权行权价格的议案》，同意对 2020 年股票期权与限制性 股票激励计划授予的股票期权行权价格进行调整。现将相关事项公告 如下： 一、本激励计划已履行的相关审批程序 证券代码：002819 证券简称：东方中科 公告编号：2023-067 北京东方中科集成科技股份有限公司 关于调整 2020 年股票期权与限制性股票 1、2020 年 4 月 28 日，公司第四届董事会第十九次会议审议通 过了《关于<北京东方中科集成科技股份有限公司 2020 年股票期权与 限制性股票激励计划（草案）>及其摘要的议案》《关于公司<2020 年 股票期权与限制性股票激励计划实施考核管理办法>的议案》等相关 议案。公司第四届监事会第十七次会议审议通过上述相关议案并发表 同意意见。公司独立董事对相关事 ...

证券代码：002819 证券简称：东方中科 公告编号：2023-065 北京东方中科集成科技股份有限公司 第五届监事会第十八次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 北京东方中科集成科技股份有限公司第五届监事会第十八次会 议于 2023 年 8 月 29 日以通讯方式召开，会议以投票方式表决。会议 通知已于 2023 年 8 月 18 日通过专人送达、邮件等方式送达给全体监 事。本次会议应到监事 3 名，实到监事 3 名。会议的召集、召开程序 符合《公司法》和《公司章程》的有关规定。 会议由监事会主席魏伟女士主持，与会监事对各项议案进行审议、 表决，形成如下决议： 1、审议通过《<2023 年半年度报告全文>及摘要》 经审核，监事会认为：董事会编制和审议的公司《<2023 年半年 度报告全文>及摘要》的程序符合法律、行政法规及中国证监会的规 定，报告内容真实、准确、完整地反映了上市公司的实际情况，不存 在任何虚假记载、误导性陈述或者重大遗漏。 2、审议通过《董事会关于 2023 年半年度募集资金存放与使用情 况的专项报告》 经审核，监事会 ...

证券代码：002819 证券简称：东方中科 公告编号：2023-063 北京东方中科集成科技股份有限公司 2022年度分红派息实施公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整， 没有虚假记载、误导性陈述或重大遗漏。 特别提示： 北京东方中科集成科技股份有限公司（以下简称"本公司"或"公 司"）2022 年年度利润分配预案已经 2023 年 6 月 30 日召开的 2022 年年度股东大会审议通过。现将利润分配方案实施事宜公告如下： 一、股东大会审议通过权益分派方案等情况 1、公司2022年度股东大会审议通过的分派方案为：以截至2023 年4月10日公司总股本305,846,302股剔除回购专户上 已回 购股份 51,300股后的总股本305,795,002股为基数，向全体股东每10股派发现 金0.6元人民币（含税），预计分配现金红利约18,347,700.12元，不送 红股，不以资本公积金转增股本。 自分配预案披露至实施利润分配的股权登记日期间，公司股本若 因新增股份上市、股权激励行权、可转债转股、股份回购等原因发生 变化的，将按照分配比例不变的原则对现金股利总额进行相应调整。 2、自分配方 ...

Financial Performance - The net loss for the first quarter was CNY 53,905,786.84, compared to a net loss of CNY 13,796,328.43 in the same period last year, representing an increase in loss of approximately 290.5%[25] - The operating profit showed a loss of CNY 57,139,250.80, worsening from a loss of CNY 13,602,920.55 year-over-year[25] - The net profit attributable to shareholders was -¥33,421,489.70, representing a decrease of 276.45% from -¥8,878,144.75 in the same period last year[31] - The weighted average return on net assets was -1.00%, compared to -0.23% in the previous year[31] - The net loss attributable to the parent company was ¥33,421,489.70, compared to a loss of ¥8,878,144.75 in the previous period, indicating a significant decline in profitability[44] - Basic earnings per share for the current period were -0.1093, worsening from -0.0279 in the previous period[44] Revenue and Costs - The company's operating revenue for Q1 2023 was ¥632,625,421.53, an increase of 9.94% compared to ¥575,407,115.00 in the previous year[31] - Total operating revenue for the current period reached ¥632,625,421.53, an increase of 9.2% compared to ¥575,407,115.00 in the previous period[41] - Total operating costs amounted to ¥697,736,031.27, up 16.7% from ¥597,912,459.48 in the prior period, with operating costs specifically rising from ¥476,350,161.99 to ¥521,346,586.59[41] Assets and Liabilities - Total non-current assets increased by 43.89% to ¥15,463,960.06 compared to the beginning of the period[6] - The total assets decreased from CNY 5,154,039,762.40 to CNY 4,992,804,836.01, a decline of approximately 3.14%[21] - The company's long-term equity investments increased from CNY 3,327,050.35 to CNY 3,976,005.61, reflecting a growth of approximately 19.5%[21] - The total non-current liabilities decreased from CNY 1,220,157,594.86 to CNY 1,111,417,452.70, a reduction of about 8.9%[21] - The company’s total liabilities decreased from CNY 3,017,197,357.54 to CNY 2,933,000,000.00, a decrease of approximately 2.8%[21] - The total liabilities decreased to ¥1,209,353,400.98 from ¥1,319,761,714.24, reflecting a reduction in financial obligations[41] - The total equity attributable to shareholders decreased to ¥3,322,894,791.00 from ¥3,353,237,106.99, indicating a decline in shareholder value[41] Cash Flow - Net cash flow from investment activities surged by 222.04% to ¥73,408,311.15, mainly due to the maturity of financial products[7] - Net cash flow from financing activities improved by 145.81% to ¥23,796,457.93, resulting from increased borrowings[7] - The net cash flow from operating activities was -¥281,978,395.69, a decline of 21.88% compared to -¥231,354,219.53 in the previous year[31] - The company reported a net cash outflow of ¥184,448,922.90 in the current period, compared to an outflow of ¥260,216,174.67 in the previous period, indicating improved cash management[47] - Cash received from operating activities totaled ¥1,308,889,335.25, up from ¥1,007,502,506.51 in the previous year[27] - Cash paid for purchasing goods and services was ¥831,286,617.29, an increase from ¥551,190,470.24 in the previous year[27] - The cash flow from investment activities included cash recovered from investments amounting to ¥168,228,356.16, up from ¥130,000,000.00 in the previous year[27] - The company experienced a decline in cash and cash equivalents, with a balance of ¥1,066,248,282.06 at the end of the reporting period, down from ¥1,274,591,208.39 at the beginning of the year[38] - Cash and cash equivalents at the end of the period were ¥1,048,568,961.33, down from ¥1,267,542,401.09 at the end of the previous period[47] Expenses - Management expenses rose by 81.80% to ¥57,486,308.77, primarily due to the addition of new subsidiaries[6] - R&D expenses increased by 46.72% to ¥56,871,799.61, reflecting a stronger focus on research and development initiatives[6] - Research and development expenses increased to ¥56,871,799.61 from ¥38,763,100.64, highlighting a focus on innovation[41] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 17,166[7] - The largest shareholder, Dongfang Keyi Holdings Group Co., Ltd., holds 24.87% of the shares[7] Other Financial Metrics - Credit impairment losses increased by 136.55% to -¥3,962,618.82, indicating a rise in provisions for credit losses[7] - Asset disposal gains rose significantly by 3532.37% to ¥2,608,327.71, due to increased income from leasing asset disposals[7] - The company reported a significant increase in other comprehensive income, which was not detailed in the provided data, suggesting potential improvements in investment performance[25] - The company’s deferred tax assets increased from CNY 54,427,754.13 to CNY 61,927,962.02, an increase of about 13.8%[21] - The company is focusing on enhancing its investment strategies and exploring new market opportunities, although specific details were not provided in the report[25]

Financial Performance - The total operating revenue for Q4 2022 was approximately CNY 1.27 billion, showing a significant increase compared to previous quarters[13]. - The net profit attributable to shareholders for Q4 2022 was CNY 907.13 million, a recovery from a loss in the previous quarter[13]. - The company reported a net cash flow from operating activities of CNY 84.28 million in Q4 2022, indicating improved cash generation[13]. - The company's operating revenue for 2022 was CNY 3,022,814,268.86, an increase from CNY 1,848,389,467.26 in 2021, representing a growth of approximately 63.5%[55]. - The net profit attributable to shareholders for 2022 was ¥888,840,608.20, a significant increase of 417.19% from ¥171,858,699.94 in 2021[70]. - The basic earnings per share for 2022 was ¥2.8712, up 183.83% from ¥1.0116 in 2021[70]. - The company reported a significant increase in revenue, achieving a total of 1.2 billion CNY, representing a 15% year-over-year growth[92]. - The company reported a net profit margin of 12%, up from 10% in the previous year, indicating improved operational efficiency[92]. Asset Management - The total non-current asset disposal gain for 2022 was CNY 897,850.18, primarily from fixed asset disposals[14]. - The total liabilities of the company at the end of 2022 were reported to be CNY 2.5 billion, reflecting a stable financial position[18]. - The total assets at the end of 2022 were ¥5,154,039,762.40, a decrease of 2.27% from ¥5,273,831,637.82 at the end of 2021[70]. - The net assets attributable to shareholders decreased by 12.97% to ¥3,353,237,106.99 at the end of 2022 from ¥3,852,869,981.60 at the end of 2021[70]. - The total assets of the company increased to 3 billion CNY, reflecting a 10% growth from the previous fiscal year[92]. Cash Flow and Investments - The company reported a net cash flow from operating activities of -¥130,715,792.30 in 2022, a decline of 153.47% compared to ¥244,473,998.14 in 2021[70]. - The company achieved a significant investment income of CNY 1.00 billion from trading financial assets in 2022, a notable recovery from a loss in the previous year[15]. - The company reported a total of 52,300 million yuan in entrusted financial management, with an outstanding balance of 17,405 million yuan[183]. - The company’s financial management includes 38,000 million yuan in bank financial products and 8,000 million yuan in securities financial products, all sourced from self-owned funds[183]. Strategic Plans and Market Expansion - The company plans to expand its market presence and invest in new technologies, although specific financial targets were not disclosed[18]. - The company is focusing on strategic acquisitions to enhance its competitive edge in the market[18]. - The company plans to enhance market research for its self-operated leasing assets to mitigate risks associated with technological obsolescence[78]. - Market expansion plans include entering two new international markets by Q3 2023, aiming for a 5% market share in each[92]. - The company is considering strategic acquisitions to enhance its product portfolio, with a budget of 300 million CNY for potential deals[92]. Research and Development - The company is actively engaged in research and development of new technologies to enhance its market position and expand its product offerings[55]. - The company is investing in R&D, allocating 150 million CNY towards the development of new technologies and products[92]. - The company has invested significantly in R&D, impacting its financial performance in recent years[195]. Corporate Governance and Compliance - The company has committed to ensuring the accuracy and completeness of its financial reports, as stated by the management team[43]. - The company has not reported any significant discrepancies between its financial indicators and previously disclosed quarterly or semi-annual reports[56]. - The company is focusing on improving its corporate governance structure to ensure compliance with listing requirements and protect minority shareholders' rights[80]. - The company has not faced any penalties or violations during the reporting period[118]. - The company has not identified any major defects in its non-financial reporting, indicating a strong governance framework[143]. Employee Management - The total number of employees at the end of the reporting period was 1,805, with 299 in the parent company and 1,506 in major subsidiaries[103]. - The company has established a fair and effective evaluation system for senior management, with performance assessments based on operational results[110]. - The company will continue to optimize its compensation management system to enhance market competitiveness and employee retention[131]. - The company has conducted internal control training for all employees to enhance risk control awareness and compliance[140]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 13,667, down from 17,166 at the end of the previous month[154]. - The largest shareholder, Dongfang Keyi Holding Group Co., Ltd., holds 24.87% of the shares, totaling 76,064,719 shares[155]. - The company repurchased and canceled 12,831,427 shares due to the failure of Wanlihong to meet the 2021 performance commitment, reducing the total share capital from 318,179,769 to 305,348,342 shares[152]. - The shareholding structure shows that the top 10 shareholders hold a significant portion of the company's equity, with the top three shareholders alone accounting for over 50%[155]. Performance Commitments - The company committed to achieving performance targets of CNY 71 million, 210 million, 310 million, and 390 million over four years, with ongoing fulfillment[122]. - The company's performance commitment for the reporting period was not met, triggering compensation obligations from the performance commitment party[174]. - Wanlihong's net profit for 2020, 2021, and 2022 was 71.13 million, 111.64 million, and -114.06 million RMB respectively, with a cumulative net profit of 70.69 million RMB[195]. - The company's commitment to net profit for the same years was 71 million, 210 million, and 310 million RMB, totaling 591 million RMB[195].